IP Verse

Transgenic Mice Expressing Chimeric Major Histocompatibility Complex (Mhc) Class Ii Molecules - EP2967015

PATENT ANALYSIS

Patent Details

Grant Date
Aug 9, 2023
Company
REGENERON PHARMACEUTICALS, INC.
Oppositions

WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB

More patents of Regeneron Pharmaceuticals, Inc.

EP4011915

EP2967015

EP3384049

Want to monitor this patent?

Feel free to send us a message here and we will get back to you